Varicella-zoster virus-specific cell-mediated immunity in subjects with herpes zoster

Journal of Immunological Methods

Volumn 377, Issue 1-2, 2012, Pages 53-55

  Otani, Naruhito ^a   Yamanishi, Kiyofumi ^a   Sakaguchi, Yoshiko ^a   Imai, Yasutomo ^a   Shima, Masayuki ^a   Okuno, Toshiomi ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Cell mediated immunity; Herpes zoster; IFN ; Vaccine; Varicella zoster virus

Indexed keywords

GAMMA INTERFERON; VARICELLA ZOSTER VACCINE; VIRUS ANTIBODY;

ADULT; AGED; ANTIBODY TITER; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HERPES ZOSTER; HUMAN; IMMUNE RESPONSE; INTERFERON GAMMA RELEASE ASSAY; MALE; PRIORITY JOURNAL; VARICELLA ZOSTER VIRUS; VIRUS STRAIN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNITY, CELLULAR; INTERFERON-GAMMA; MALE; MIDDLE AGED; YOUNG ADULT;

HERPES ZOSTER; HUMAN HERPESVIRUS 3;

EID: 84857783941     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2012.01.003     Document Type: Article

References (9)

1. Gnann J.W., Whitley R.J. Clinical practice. Herpes zoster. N. Engl. J. Med. 2002, 347:340.
2. Hata A., Asanuma H., Rinki M., Sharp M., Wong R.M., Blume K., Arvin A.M. Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants. N. Engl. J. Med. 2002, 347:26.
3. Hope-Simpson R.E. The nature of herpes zoster: a long-term study and a new hypothesis. Proc. R. Soc. Med. 1965, 58:9.
4. Levin M.J., Smith J.G., Kaufhold R.M., Barber D., Hayward A.R., Chan C.Y., Chan I.S., Li D.J., Wang W., Keller P.M., Shaw A., Silber J.L., Schlienger K., Chalikonda I., Vessey S.J., Caulfield M.J. Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine. J. Infect. Dis. 2003, 188:1336.
5. Otani N., Baba K., Okuno T. Interferon-gamma release assay: a simple method for detection of varicella-zoster virus-specific cell-mediated immunity. J. Immunol. Methods 2009, 351:71.
6. Sadaoka K., Okamoto S., Gomi Y., Tanimoto T., Ishikawa T., Yoshikawa T., Asano Y., Yamanishi K., Mori Y. Measurement of varicella-zoster virus (VZV)-specific cell-mediated immunity: comparison between VZV skin test and interferon-gamma enzyme-linked immunospot assay. J. Infect. Dis. 2008, 198:1327.
7. Weinberg A., Levin M.J. VZV T cell-mediated immunity. Curr. Top. Microbiol. Immunol. 2010, 342:341.
8. Weinberg A., Zhang J.H., Oxman M.N., Johnson G.R., Hayward A.R., Caulfield M.J., Irwin M.R., Clair J., Smith J.G., Stanley H., Marchese R.D., Harbecke R., Williams H.M., Chan I.S., Arbeit R.D., Gershon A.A., Schödel F., Morrison V.A., Kauffman C.A., Straus S.E., Schmader K.E., Davis L.E., Levin M.J. US Department of Veterans Affairs (VA) Cooperative Studies Program Shingles Prevention Study Investigators: varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine. J. Infect. Dis. 2009, 200:1068.
9. Yawn B.P., Wollan P.C., Kurland M.J., St Sauver J.L., Saddier P. Herpes zoster recurrences more frequent than previously reported. Mayo Clin. Proc. 2011, 86:88.